Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
Hyperpolarised magnetic resonance imaging (HP 13C-MRI) is an emerging clinical technique to detect [1-13C]lactate production in prostate cancer (PCa) following intravenous injection of hyperpolarised [1-13C]pyruvate. Here we differentiate clinically significant PCa from indolent disease in a low/int...
Main Authors: | Sushentsev, N, McLean, MA, Warren, AY, Benjamin, AJV, Brodie, C, Frary, A, Gill, AB, Jones, J, Kaggie, JD, Lamb, BW, Locke, MJ, Miller, JL, Mills, IG, Priest, AN, Robb, FJL, Shah, N, Schulte, RS, Graves, MJ, Gnanapragasam, VJ, Brindle, KM, Barrett, T, Gallagher, FA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2022
|
Similar Items
-
The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T1 relaxometry in patients with prostate cancer
by: Nikita Sushentsev, et al.
Published: (2020-11-01) -
Cardiac applications of hyperpolarised magnetic resonance
by: Timm, K, et al.
Published: (2018) -
Hyperpolarised MRI of cardiac inflammation and repair
by: Lewis, A, et al.
Published: (2017) -
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence
by: Sushentsev, N, et al.
Published: (2023) -
Clinical Applications of Hyperpolarised Xenon-129 MRI
by: Kher Lik Ng, et al.
Published: (2024-12-01)